Results 21 to 30 of about 2,461 (207)

Does topical brimonidine tartrate help NAION? [PDF]

British Journal of Ophthalmology, 2003
There is no proved treatment for non-arteritic anterior ischaemic optic neuropathy (NAION). Topical brimonidine tartrate has been reported to have a neuroprotective benefit for retinal ganglion cells following experimental elevation of intraocular pressure and optic nerve injury in the rat, which is blocked with coadministration of the α-2 antagonist ...
H E, Fazzone, M J, Kupersmith, J, Leibmann   +2 more
openaire   +4 more sources

Modification of contact lenses via metal‐organic frameworks for glaucoma treatment

Aggregate
The prevention of blindness from glaucoma requires multiple treatments to lower intraocular pressure. Here, human contact lenses are modified with highly porous metal‐organic frameworks with sustained release of brimonidine for prolonged glaucoma ...
Alexey V. Yaremenko, Roman O. Melikov, Nadezhda A. Pechnikova, Iaroslav B. Belyaev, Alina Ringaci, Tamara V. Yaremenko, Aziz B. Mirkasymov, Alexandr A. Tamgin, Vladislav I. Rodionov, Sofya M. Dolotova, Grigory A. Plisko, Evgeny D. Semivelichenko, Anna S. Rogova, Albert R. Muslimov, Arina S. Ivkina, Dmitry Yu. Ivkin, Valery P. Erichev, Sergey M. Deyev, Sergey E. Avetisov, Yongjiang Li, Hai‐Jun Liu, Ivan V. Zelepukin   +21 more
doaj   +2 more sources

Late Reverse Pupillary Block After Scleral Fixation With Yamane Technique: A Case Report. [PDF]

Case Rep Ophthalmol Med
Introduction The Yamane technique is a transconjunctival, sutureless method for scleral fixation of intraocular lenses (IOL) in cases lacking capsular support. While widely adopted because of its efficacy and safety, rare late complications such as IOL subluxation have been reported.
Chaves-Samaniego MJ, Awatramani G, Hussain N.   +2 more
europepmc   +2 more sources

Visual field testing and glaucoma drug prescribing patterns in Australia. [PDF]

Ophthalmic Physiol Opt
Abstract Purpose To examine glaucoma practice patterns in Australia, focusing on visual field test uptake and antiglaucoma drug prescribing by optometrists and ophthalmologists. Design A serial cross‐sectional study was conducted to describe visual field testing charges and compare them to changes in comprehensive eye examination charges, as well as to
Jan CL, Vingrys A, Stafford RS, Kang M, Shang X, Hu W, Liu J, Joseph S, He M.   +8 more
europepmc   +2 more sources

Is Brimonidine Tartrate Gel .5% Effective in Reducing Facial Erythema of Rosacea? [PDF]

, 2016
OBJECTIVE: The objective of this selective Evidence Based Medicine (EBM) review is to determine whether or not “Is Brimonidine Tartrate gel 0.5% effective in reducing facial erythema of Rosacea?” STUDY DESIGN: Review of two randomized controlled trials ...
Aggarwal, Meeta
core   +3 more sources

Charles Bonnet syndrome precipitated by brimonidine tartrate eye drops [PDF]

British Journal of Ophthalmology, 2003
Brimonidine tartrate (BT) (Alphagan) is an α-2 adrenergic agonist marketed for treatment of primary open angle glaucoma (POAG) which may have neuroprotective effects.1 One report of acute delusional psychosis with auditory hallucinations in a 68 year old man treated for POAG has been published,2 and use of BT eye drops in an infant resulted in coma and
Robert L. Tomsak
openaire   +3 more sources

Consistent Intraocular Pressure Reduction by Solid Drug Nanoparticles in Fixed Combinations for Glaucoma Therapy

Advanced Science
Efficient topical drug delivery remains a significant challenge in glaucoma management. Although nanoparticle formulations offer considerable promise, their complex preparation processes, co‐delivery issues, and batch consistency have hindered their ...
Da Huang, Pedro Norat, Lin Qi, Anna Chernatynskaya, James D. Cole, Vimalin Jeyalatha Mani, Lei Xu, Xiaorong Liu, Hu Yang   +8 more
doaj   +2 more sources

Drug-loaded chitosan film prepared via facile solution casting and air-drying of plain water-based chitosan solution for ocular drug delivery [PDF]

Bioactive Materials, 2020
Chitosan is a nature-based polymer with low toxicity, excellent biocompatibility and biodegradability. However, the intractable solubility of chitosan in water and most conventional solvents hampers its biomedical applications.
Boxuan Li, Juan Wang, Qin Gui, Hu Yang
doaj   +3 more sources

Brimonidine tartrate-induced delayed hypersensitivity reaction

TNOA Journal of Ophthalmic Science and Research, 2020
Chitaranjan Mishra, Vijayalakshmi A Senthilkumar   +1 more
doaj   +2 more sources

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]

Clinical Ophthalmology, 2015
The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum] Tsumura T, Yoshikawa K, Kimura T, et al. Clin Ophthalmol. 2014;8:1681–1687. 
Tsumura T, Yoshikawa K, Kimura T, Suzumura H, Kawashima M, Nanno M, Ishijima K, Takeda R   +7 more
doaj   +1 more source